全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Bilateral Radial Ulnar Synostosis and Vertebral Anomalies in a Child with a De Novo 16p13.3 Interstitial Deletion

DOI: 10.1155/2013/149085

Full-Text   Cite this paper   Add to My Lib

Abstract:

We describe an 8-year-old boy with developmental delay, clinical bilateral radial ulnar synostosis, Klippel-Feil anomaly, and other vertebral deformities who was found to have a de novo deletion of 114.5kb at 16p13.3. The deletion contains five genes and three miRNAs. The genes are E4F1, DNASE1L2, ECI1, RNPS1, and ABCA3; miRNAs are MIR3677, MIR940, and MIR4717. The specific deletion has never been previously reported. We describe the phenotype of the boy and review the genes in the deleted region. None of the regulatory elements have any known linkage to skeletal formation and/or maintenance. We believe this deletion is causative given that it was de novo and that this patient cannot be easily explained as having any other specific recognizable pattern of human malformation. 1. Introduction Many of the reports on chromosome 16p13.3 gene deletions are in relation to the Rubinstein-Taybi syndrome, alpha thalassemia mental retardation, polycystic kidney disease, and familial Mediterranean fever. Chromosome 16p13.3 gene deletions associated with the Rubinstein-Taybi syndrome are discussed in depth in articles by Wallerstein et al. and Hennekam et al., respectively [1, 2]. We report a child with developmental delay, bilateral radial ulnar synostosis, Klippel-Feil anomaly, and other vertebral deformities with a de novo interstitial deletion of 114.5?kb on chromosome 16p found using chromosomal microarray. The deleted region contains five genes and three miRNAs of unclear clinical significance. We are not aware of reports of gene deletions that overlap with the 114.5kb deletion described here. The purpose of this paper is to describe our patient’s unique phenotype and discuss the possible genotype-phenotype correlations of the deleted region. 2. Clinical Report Past medical history was significant for term birth with complication of preeclampsia of unknown etiology. He had no neonatal complications. His birth weight was 7 lbs 3?oz. Family history was unremarkable for skeletal disorders. Younger full sibling sister was healthy without issues. The patient had a history of developmental delay and was in an early intervention program in California. He walked around age 2, spoke at age 3, and had phrases around age 4. He also was not toilet trained until age 4. Neurodevelopmental assessment at the age of 8 years showed a Wechsler Intelligence Scale for Children Fourth Edition (WISC IV) verbal comprehension of 89, working memory of 80, perceptional reasoning of 96, processing speed of 83, and low average full scale IQ of 84. He had a history of two febrile seizures,

References

[1]  R. Wallerstein, C. E. Andersen, B. Hay et al., “Submicroscopic deletions at 16p13.3 in Rubinstein-Taybi syndrome: frequency and clinical manifestations in a North American population,” Journal of Medical Genetics, vol. 34, no. 3, pp. 203–206, 1997.
[2]  R. C. M. Hennekam, M. Tilanus, B. C. J. Hamel et al., “Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects,” The American Journal of Human Genetics, vol. 52, no. 2, pp. 255–262, 1993.
[3]  R. J. Rooney, R. R. Daniels, N. A. Jenkins et al., “Chromosomal location and tissue expression of the gene encoding the adenovirus E1A-regulated transcription factor E4F in humans and mice,” Mammalian Genome, vol. 9, no. 4, pp. 320–323, 1998.
[4]  L. le Cam, M. Lacroix, M. A. Ciemerych, C. Sardet, and P. Sicinski, “The E4F protein is required for mitotic progression during embryonic cell cycles,” Molecular and Cellular Biology, vol. 24, no. 14, pp. 6467–6475, 2004.
[5]  W. J. Kent, C. W. Sugnet, T. S. Furey et al., “The human genome browser at UCSC,” Genome Research, vol. 12, no. 6, pp. 996–1006, 2002.
[6]  A. M. Rodriguez, D. Rodin, H. Nomura, C. C. Morton, S. Weremowicz, and M. C. Schneider, “Identification, localization, and expression of two novel human genes similar to deoxyribonuclease I,” Genomics, vol. 42, no. 3, pp. 507–513, 1997.
[7]  U. Janssen, T. Fink, P. Lichter, and W. Stoffel, “Human mitochondrial 3,2-trans-enoyl-CoA isomerase (DCI): gene structure and localization to chromosome 16p13.3,” Genomics, vol. 23, no. 1, pp. 223–228, 1994.
[8]  S. Shulenin, L. M. Nogee, T. Annilo, S. E. Wert, J. A. Whitsett, and M. Dean, “ABCA3 Gene Mutations in Newborns with Fatal Surfactant Deficiency,” New England Journal of Medicine, vol. 350, no. 13, pp. 1296–1303, 2004.
[9]  W.-O. Lui, N. Pourmand, B. K. Patterson, and A. Fire, “Patterns of known and novel small RNAs in human cervical cancer,” Cancer Research, vol. 67, no. 13, pp. 6031–6043, 2007.
[10]  M. Nelson, S. Quinonez, T. Ackley, R. K. Iyer, and J. W. Innis, “Multiple congenital anomalies and developmental delay in a boy associated with a de novo 16p13.3 deletion,” American Journal of Medical Genetics, Part A, vol. 155, no. 3, pp. 612–617, 2011.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133